Medical professionals and technology advocates are examining new research highlighting the viability of artificial intelligence (AI) in bridging healthcare gaps for early Autism Spectrum Disorder (ASD) screening. Published on April 7 in the Journal of Medical Internet Research, the semistructured focus group study explored the feasibility, acceptability, and ethical barriers of deploying AI-powered diagnostic tools in Egypt, offering vital insights for low- and middle-income countries with similar healthcare challenges.
According to the study, autism is frequently underdiagnosed in developing regions due to a combination of limited access to medical specialists, deeply rooted sociocultural stigma, and fragmented screening systems. Researchers posited that AI-powered tools could revolutionize early detection by providing low-cost and highly accessible assessments to underserved populations. However, the study emphasized that the successful adoption of such technologies heavily depends on stakeholder trust, strict ethical safeguards, and proper alignment with existing local health system capacities.
To understand the practical implications of this technology, researchers conducted qualitative focus group discussions involving 49 participants from both urban and rural governorates. The groups consisted of 21 parents of children with ASD and 28 healthcare professionals. The discussions were analyzed using Braun and Clarke’s reflexive thematic analysis to monitor participant diversity and gauge the actual sentiments of those navigating the healthcare system.
The findings revealed an atmosphere of cautious optimism among the respondents. Parents of children with ASD primarily emphasized the advantages of accessibility and the speed of AI screening. In contrast, healthcare professionals approached the technology with more scrutiny, highlighting significant concerns regarding diagnostic reliability, the necessity for cultural adaptation, and the establishment of robust data governance.
Through the focus groups, five major themes emerged regarding the integration of AI in medicine. Participants established that AI must be treated as a supportive tool to assist nonspecialists and improve scalability, rather than acting as a replacement for actual clinicians. They also stressed the need for cultural and contextual adaptation to ensure the AI’s relevance to local communities, while raising valid concerns over privacy, consent, data security, and algorithmic opacity.
Furthermore, the study highlighted the technology’s capability to reduce diagnostic inequities by addressing the stark disparities between urban and rural healthcare access through community-based deployment. Ultimately, the consensus pointed to a strong preference for hybrid AI-human models. Participants agreed that for AI screening to be adopted successfully, it must be accompanied by cultural sensitivity, continuous human oversight, and comprehensive digital literacy support for its users.
The authors concluded that AI-powered ASD screening holds immense potential to advance equitable early detection in historically underserved areas. By detailing the critical need for transparent data governance and culturally adaptive designs, the researchers hope the findings will serve as an evidence-based roadmap for policymakers, technologists, and health system leaders looking to implement equity-focused AI tools in the medical field.| Sheenalei Briana Rayos
